Vima »

Arcutis Biotherapeutics shares owned by Vima

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Vima from 13F filings

Historical chart of Vima investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Vima consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Vima

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.7k 3.0k 3.23

More positions owned by Vima

Invesco Exchange-traded Fd Tr S&p 500 Garp Etf Etf (SPGP)
Apple (AAPL)
Vaneck Etf Tr Gold Miners Etf Etf (GDX)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Tr 20 Yr Treas Bd Etf Etf (TLT)
Berkshire Hathaway Inc Del Cl B Del Cl B New
Ishares Gold Tr Ishares Gold Tr (IAU)
Vanguard Malvern Fds Short-term Inflation Protected Secs Index Fd Etf FDS (VTIP)
Invesco Exchange-traded Fd Tr Ii Sr Ln Etf SR LN STF (BKLN)
Marathon Digital Holdings In (MARA)
John Hancock Exchange Traded Fd Tr Multifactor Mid Cap Etf Mid Cap Etf (JHMM)
First Tr Exchange-traded Fd Viii Ft Vest U S Equity Enhance & Equity Etf November TR (XNOV)
Ellsworth Fund (ECF)
First Tr Exchange-traded Fd Vii Alt Absolute Return Strategy Etf Etf (FAAR)

View all positions for Vima

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics